Transthyretin amyloid cardiomyopathy #ATTR:
A paradigm for advancing precision medicine
#CardioSky
academic.oup.com/eurheartj/ar...
@escardio.bsky.social @jimjanuzzi.bsky.social @hvanspall.bsky.social @anastasiasmihaili.bsky.social @load-dependent.bsky.social @victoriadelgadomd.bsky.social
🚀 Transthyretin Amyloid Cardiomyopathy: A Paradigm for Advancing Precision Medicine 🚀
📖 Read the full article: doi.org/10.1093/eurh...
#Cardiology #PrecisionMedicine #Amyloidosis #ATTRCM @escardio.bsky.social
Does tafamidis treatment associate w/ increased survival in octogenarians pts w/ wild-type amyloid transthyretin cardiomyopathy? Carlos Aguiar discusses recent real-world data on Cardiology This Week Summary #ESCTVToday bit.ly/4iW9S9I
Sign up for reminders so you Never Miss a Beat bit.ly/4eqyaac
🧠 Can Imaging Be a Surrogate Endpoint in Amyloidosis Trials?
A recent JACC:CVI review by Dorbala et al. highlights the role of imaging biomarkers in clinical trials for amyloidosis.
www.jacc.org/doi/abs/10.1...
🧠 Can Imaging Be a Surrogate Endpoint in Amyloidosis Trials?
A recent JACC:CVI review by Dorbala et al. highlights the role of imaging biomarkers in clinical trials for amyloidosis.
www.jacc.org/doi/abs/10.1...
